Methylation of the WNT5A gene is frequently detected in early gastric carcinoma

Hepato-Gastroenterology

Volumn 59, Issue 120, 2012, Pages 2661-2663

  Hibi, Kenji ^a   Sakata, Makiko ^a   Yokomizo, Kazuaki ^a   Kitamura, Yo Hei ^a   Sakuraba, Kazuma ^a   Shirahata, Atsushi ^a   Goto, Tetsuhiro ^a   Mizukami, Hiroki ^a   Saito, Mitsuo ^a   Ishibashi, Kazuyoshi ^a   Kigawa, Gaku ^a   Nemoto, Hiroshi ^a   Sanada, Yutaka ^a  

^a SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

Author keywords

Gastric cancer; Quantitative methylation specific PCR; WNT5A

Indexed keywords

WNT5A PROTEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CORRELATIONAL STUDY; DISEASE SEVERITY; DNA METHYLATION; EARLY CANCER; FEMALE; GENETIC ANALYSIS; HUMAN; LYMPH NODE METASTASIS; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STOMACH CARCINOMA; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; CARCINOMA; CHI-SQUARE DISTRIBUTION; DNA METHYLATION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PHENOTYPE; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS; STOMACH NEOPLASMS; WNT PROTEINS;

EID: 84872073670     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge09664     Document Type: Article

References (13)

1. Yasui W, Yokozaki H, Fujimoto J, et al.: Genetic and epigenetic alterations in multistep carcinogenesis of the stomach. J Gastroenterol 2000; 35:111-115.
2. Chen W-D, Han ZJ, Skoletsky J, et al.: Detection in fecal DNA of colon cancer-specific methylation of the non-expressed vimentin gene. J Natl Cancer Inst 2005; 97:1124-1132.
3. Leung SY, Yuen ST, Chung LP, Chu KM, Chan AS, Ho JC: hMLH1 promoter methylation and lack of hMLH1 expression in sporadic gastric carcinomas with high-frequency microsatellite instability. Cancer Res 1999; 59:159-164.
4. Oue N, Shigeishi H, Kuniyasu H, et al.: Promoter hypermethylation of MGMT is associated with protein loss in gastric carcinoma. Int J Cancer 2001; 93:805-809.
5. Kang SH, Choi HH, Kim SG, et al.: Transcriptional inactivation of the tissue inhibitor of metalloproteinase-3 gene by DNA hypermethylation of the 5′-CpG island in human gastric cancer cell lines. Int J Cancer 2000; 86:632-635.
6. Shim YH, Kang GH, Ro JY: Correlation of p16 hypermethylation with p16 protein loss in sporadic gastric carcinomas. Lab Invest 2000; 80:689-695.
7. Ying J, Li H, Yu J, et al.: WNT5A exhibits tumor-suppressive activity through antagonizing the WNT/β-catenin signaling, and is frequently methylated in colorectal cancer. Clin Cancer Res 2008; 14:55-61.
8. Hibi K, Taguchi M, Nakayama H, et al.: Molecular detection of p16 promoter methylation in the serum of patients with esophageal squamous cell carcinoma. Clin Cancer Res 2001; 7:3135-3138.
9. Fuchs CS, Mayer RJ: Gastric carcinoma. N Engl J Med 1995; 333:32-41.
10. Hibi K, Mizukami H, Goto T, et al.: WNT5A gene is aberrantly methylated from the early stages of colorectal cancers. Hepatogastroenterol 2009; 56:1007-1009.
11. Hibi K, Robinson CR, Booker S, et al.: Molecular detection of genetic alterations in the serum of colorectal cancer patients. Cancer Res1998; 58:1405-1407.
12. Koike M, Hibi K, Kasai Y, et al.: Molecular detection of circulating esophageal squamous cell cancer cells in the peripheral blood. Clin Cancer Res 2002; 8:2879-2882.
13. Dong SM, Traverso G, Johnson C, et al.: Detecting colorectal cancer in stool with the use of multiple genetic targets. J Natl Cancer Inst 2001; 93:858-865.